2nd Quarter - Report

NATIONAL ASSOCIATION OF CHAIN DRUG STORES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES

Firm
Client
Income
—
Expenses
$440,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

H.R. 1173, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft. H.R. 1166, the E-Fencing Enforcement Act of 2008, as related to the prosecution of organized theft. S. 470, Combating Organized Retail Crime Act of 2009, as related to the prosecution of organized theft.

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
YONG CHOE —
HEIDI ANN ECKER —
KATHERINE FRY —
CAROL KELLY —
PAUL T KELLY —
JULIE A KHANI —
KEVIN N NICHOLSON —
MARC SCHLOSS New —

Contacted: White House Office; Food & Drug Administration (FDA); Defense, Dept of (DOD); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Consumer Product Safety Commission (CPSC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 1173 (111th), S. 470 (111th), H.R. 1166 (111th)

Defense DEF

H.R.2647/S.1390/S.1391, National Defense Authorization Act for Fiscal Year 2010, as related to pharmacy participation in the TRICARE program.

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
YONG CHOE —
HEIDI ANN ECKER —
KATHERINE FRY —
CAROL KELLY —
PAUL T KELLY —
JULIE A KHANI —
MARC SCHLOSS New —

Contacted: Food & Drug Administration (FDA); Defense, Dept of (DOD); Drug Enforcement Administration (DEA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; Office of Natl Drug Control Policy (NDCP); Consumer Product Safety Commission (CPSC)

Bills named: S. 1390 (111th), H.R. 2647 (111th), S. 1391 (111th)

Labor Issues/Antitrust/Workplace LBR

H.R.1409/S.560, the Employee Free Choice Act of 2009, as related to labor practices during organizing efforts. Issues related to pension funding requirements and the Worker, Retiree, and Employer Recovery Act of 2008

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
YONG CHOE —
HEIDI ANN ECKER —
KATHERINE FRY —
CAROL KELLY —
PAUL T KELLY —
JULIE A KHANI —
MARC SCHLOSS New —

Contacted: Consumer Product Safety Commission (CPSC); HOUSE OF REPRESENTATIVES; White House Office; SENATE; Office of Natl Drug Control Policy (NDCP); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Defense, Dept of (DOD)

Bills named: S. 560 (111th), H.R. 1409 (111th)

Pharmacy PHA

H.R.1/S.350, the American Recovery and Reinvestment Act, related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S.726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R.1359/S.1292, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Part B surety bond requirement. H.R.1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R.3108, the Medication Therapy Management Benefits Act, related to expansion of the Medicare Part D medication therapy management benefit. S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009, as related to the importation of prescription drugs. H.R.1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals. S. 1383, Dextromethorphan Abuse Reduction Act of 2009, as related to the abuse of dextromethorphan. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. The Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement for generic drugs in the Medicaid program. Various issues related to the role of pharmacy and pharmacists in healthcare reform, including pharmacy services in the Medicare program.

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
YONG CHOE —
DIANE L DARVEY —
HEIDI ANN ECKER —
KATHERINE FRY —
CAROL KELLY —
PAUL T KELLY —
JULIE A KHANI —
KEVIN N NICHOLSON —
MARC SCHLOSS New —

Contacted: White House Office; Food & Drug Administration (FDA); Consumer Product Safety Commission (CPSC); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); SENATE

Bills named: H.R. 1298 (111th), S. 726 (111th), H.R. 1548 (111th), S. 256 (111th), S. 1232 (111th), H.R. 616 (111th), H.R. 1359 (111th), S. 350 (111th), S. 525 (111th), H.R. 2923 (111th), H.R. 759 (111th), H.R. 1427 (111th), S. 1292 (111th), S. 956 (111th), H.R. 1 (111th), H.R. 2552 (111th), H.R. 1259 (111th), S. 1336 (111th), S. 1383 (111th), H.R. 3108 (111th), S. 511 (111th), H.R. 1970 (111th), H.R. 1191 (111th), H.R. 1450 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.